ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

137 hedge funds and large institutions have $643M invested in Intra-Cellular Therapies Inc. in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 10 closing their positions.

Holders
137
Holders Change
+37
Holders Change %
+37%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
47
Increased
43
Reduced
23
Closed
10
Calls
$6.91M
Puts
$14.2M
Net Calls
-$7.33M
Net Calls Change
-$12.6M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$126M
2
Millennium Management
2
Millennium Management
New York
$21.8M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$17.4M
4
BI
4
BVF Inc
California
$15M
5
PA
5
Perceptive Advisors
New York
$14.7M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$1.06M
2
BlackRock
2
BlackRock
New York
$52M
3
Goldman Sachs
3
Goldman Sachs
New York
$3.59M
4
State Street
4
State Street
Massachusetts
$11.6M
5
GTC
5
Ghost Tree Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
VCM
151
Versant Capital Management
Arizona
– – – –
3 4 5 6
7